Additionally, a recent study revealed that syringin exerts anti-breast cancer effects through the PI3K-AKT and EGFR-RAS-RAF pathways in MDA-MB-231 and MCF-7 cells in in a culture medium with a high sugar and serum content supplemented with 12% fetal bovine serum (FBS) [67]. Here, AKT1 is linked to breast carcinoma.